Trans-Chalcone (1–3-diphenyl-2-propen-1-one) as a Therapeutic Candidate in Joint Inflammation via Reduction of TNF-α, IL-1β, IL-6, and IL-17 in Rodents: An In Vivo Study by RT-PCR and ELISA analysis

• Zeeshan Jabbar,
• Hafiz M. Irfan,
• Alamgeer,
• Aman Ullah,
• Mohamed H. Mahmoud,
• Gaber E. Batiha,
• Haseeb Ahsan,
• Ajmal Khan,
• Hamdy Kashtoh

Affiliations

Zeeshan Jabbar

College of Pharmacy, University of Sargodha, Sargodha, Pakistan

Hafiz M. Irfan

College of Pharmacy, University of Sargodha, Sargodha, Pakistan

Alamgeer

Punjab University College of Pharmacy, University of the Punjab, Lahore, Pakistan

Aman Ullah

Department of Pharmacy, Saba Medical Centre, Abu Dhabi, United Arab Emirates

Mohamed H. Mahmoud

Department of Biochemistry, College of science, King Saud University, Riyadh, Kingdom of Saudi Arabia

Gaber E. Batiha

Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, AlBeheira, Egypt

Haseeb Ahsan

Division of Blood and Marrow Transplantation, Department of Pediatrics, School of Medicine, University of Minnesota, Minneapolis, Minnesota, United States

Ajmal Khan

Natural and Medical Sciences Research Center, University of Nizwa, Nizwa, Oman

Hamdy Kashtoh

Department of Biotechnology, Yeungnam University, Gyeongsan, Gyeongbuk, Republic of Korea